The publication in the Official Gazette of the UAE on January 1, 2026, brought into effect significant changes to the regulatory landscape in the UAE.

The Crime and Policing Act 2026 introduces a universal senior manager attribution test that fundamentally transforms corporate criminal liability in the UK, extending automatic criminal responsibility to organisations across the full spectrum of UK criminal law when senior managers commit offences within their authority. With no reasonable prevention procedures defence and limited access to deferred prosecution agreements, organisations face unprecedented exposure requiring immediate strategic action and co

The clock is ticking for financial services firms to prepare for the UK's Financial Conduct Authority's (FCA) new non-financial misconduct (NFM) framework, which comes into force on September 1, 2026.

The recent muted state of the M&A market has not had the level of impact on direct lending that some observers may have expected. Panel members commented on:

The recent decision by Maine's highest court is part of a trend of state courts dismissing public nuisance claims against opioid makers and sellers.

On Monday, the SEC staff issued a no-action letter that allows registered open-end funds, including mutual funds and ETFs, to co-invest under the simplified exemptive orders that it began issuing in 2025.

FINRA adopted amendments to exempt business development companies ("BDCs") from FINRA Rule 5130 (Restrictions on the Purchase and Sale of Initial Equity Public Offerings) and from paragraph (b) (Spinning) of FINRA Rule 5131 (New Issue Allocations and Distributions) on July 23, 2025.

The CFTC and NHL have signed a groundbreaking Memorandum of Understanding establishing a framework for information sharing and cooperation to protect the integrity of professional hockey and related event contracts traded...

On March 19, 2025, the SEC staff published two new Marketing Rule FAQs that relieve issues with displaying investment performance under previous staff guidance.

Dechert’s private credit and asset-backed finance (ABF) team returned to Las Vegas from February 23–26 for SFVegas 2026, the structured finance industry’s annual cannot-miss event.

Ongoing litigation and a recently published report by FDA signal a continuing focus by the agency to investigate PFAS in food and cosmetics.

4 Real is a podcast from Dechert LLP exploring the latest trends and developments in commercial real estate finance.

The law regarding whether apps are products subject to product liability statutes remains unsettled, but the determination of their status will have a significant impact on the scope of future claims against developers.

In Roubert v. Amazon, the plaintiff employee sued Amazon after she allegedly tripped over a bolt at an Amazon warehouse and claimed injuries to her shoulder, knee, and back. 2025 WL 607060, at *1 (E.D. Pa. Feb. 25, 2025).

Procedural concerns could stymie efforts to resolve the longstanding split in authority on certification of class actions encompassing uninjured members.

Recent decisions reaffirm courts' willingness to reject arguments that a defendant waived arbitration rights by participating in litigation.

This year, the highest appellate courts in Washington, California, and West Virginia are set to rule on critical tort law issues.

This monthly newsletter examines significant legal trends and landmark cases in product liability and mass torts, from RICO liability in fabricated medical records schemes to AI chatbot regulation and PFAS drinking water standards. The analysis covers critical developments including the Supreme Court's FIFRA preemption ruling in Roundup litigation, bankruptcy estate successor liability clarifications, and emerging issues around AI-generated expert testimony.

Courts are increasingly confronting requests for party communications with AI platforms and are applying traditional privilege and work-product principles to resolve them. Key facts likely to drive the analysis include the nature of the relationship...

This monthly newsletter examines significant legal trends and landmark cases in tort law, including the Sixth Circuit's reversal of class certification, FDA's dual approach to AI regulation in pharmaceuticals, Minnesota's upcoming PFAS ban, and the Supreme Court's expansive interpretation of federal officer removal jurisdiction. These developments carry strategic implications for businesses navigating complex litigation and regulatory compliance across multiple industries.